The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

24 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
417
NOVEL OXADIAZOLE-BASED SELECTIVE HDAC6 INHIBITORSBDB
Italfarmaco
7
Enhancer of Zeste Homolog 2 inhibitorsBDB
Glaxosmithkline
6
Pyridine compounds used as PI3 kinase inhibitorsBDB
Teligene
42
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitorsBDB
Incyte
232
Substituted tricyclic compounds as FGFR inhibitorsBDB
Incyte Holdings
79
Tropomyosin-related kinase (TRK) inhibitorsBDB
Genzyme
303
TGF-beta inhibitorsBDB
Rigel Pharmaceuticals
4
Azaspiro[4.5] decane derivatives and use thereofBDB
Purdue Pharma
353
Fused pyrroledicarboxamides and their use as pharmaceuticalsBDB
Sanofi
4
Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitorsBDB
Acetylon Pharmaceuticals
110
Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitorsBDB
H. Lundbeck
51
Pyridopyrazine derivatives and their useBDB
Zentaris
68
Chemokine receptor antagonistsBDB
Abbvie
250
Substituted-quinoxaline-type piperidine compounds and the uses thereofBDB
Purdue Pharma
170
Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereofBDB
Hanmi Pharm.
7
6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidinesBDB
Boehringer Ingelheim International
233
Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsBDB
Array Biopharma
20
CGRP receptor antagonistsBDB
Merck Sharp & Dohme
184
InhibitorsBDB
Probiodrug
6
Rational design of quinazoline-based irreversible inhibitors of human erythrocyte purine nucleoside phosphorylase.BDB
Arizona State University
7
Biochemical and cellular effects of c-Src kinase-selective pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors.BDB
Parke-Davis Pharmaceutical Research
10
Synthesis and inhibition of Src kinase activity by 7-ethenyl and 7-ethynyl-4-anilino-3-quinolinecarbonitriles.BDB
Wyeth Research
15
3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinase.BDB
University of Auckland
38
6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity.BDB
Wyeth-Ayerst Research